July 29, 2019 08:34 AM EDTUpdated 03:54 PM

As cancer detection companies thrive, Exact Sciences looks to consolidate by spending $2.8B to acquire peer Genomic Health

As predicted by Bloomberg, cancer diagnostics company Exact Sciences is buying peer Genomic Health in a $2.8 billion cash-and-stock deal.

Exact Sciences’ …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

As can­cer de­tec­tion com­pa­nies thrive, Ex­act Sci­ences looks to con­sol­i­date by spend­ing $2.8B to ac­quire peer Ge­nom­ic Health